What is the recommended treatment for acute Bell's palsy, including timing, corticosteroid dosing, antiviral use, eye protection, and follow‑up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Bell's Palsy

Immediate First-Line Treatment

Start oral corticosteroids within 72 hours of symptom onset—this is the only proven treatment that significantly improves facial nerve recovery, with 83% complete recovery at 3 months versus 63.6% with placebo. 1

Corticosteroid Regimen (Choose One)

  • Prednisolone 50 mg once daily for 10 days (preferred regimen) 1
  • Prednisone 60 mg daily for 5 days, then taper by 10 mg daily over next 5 days (alternative) 1

Critical timing: Treatment initiated beyond 72 hours provides minimal to no benefit and should generally not be started. 1, 2 The therapeutic window exists because early corticosteroids reduce facial nerve inflammation before permanent damage occurs. 2

Evidence Strength

The benefit is substantial and well-established: at 9 months, 94.4% of prednisolone-treated patients achieve complete recovery versus 81.6% with placebo. 1, 3 This represents a number needed to treat of 11 to prevent one unsatisfactory outcome. 4


Antiviral Therapy Decision

Never prescribe antiviral agents as monotherapy—they are completely ineffective when used alone. 1, 2

Optional Combination Therapy

You may offer (not mandate) the addition of antiviral therapy to corticosteroids within 72 hours, though the added benefit is minimal: 1

  • Valacyclovir 1000 mg three times daily for 7 days 5, 6
  • Acyclovir 400 mg five times daily for 10 days (alternative with lower bioavailability) 1

Rationale for optional use: Some studies show combination therapy achieves 96.5% complete recovery versus 89.7% with steroids alone 6, while the largest trials show no additional benefit 3, 5. The AAO-HNS classifies this as an "option" rather than a recommendation because the benefit is small but risks are minimal. 1


Eye Protection Protocol (Mandatory)

Implement aggressive eye protection immediately for any patient with impaired eye closure—failure to do so can result in permanent corneal damage. 1

Daytime Protection

  • Lubricating drops (e.g., hydroxypropyl methylcellulose) every 1-2 hours while awake 1
  • Sunglasses outdoors to protect against wind and particles 1

Nighttime Protection

  • Ophthalmic ointment at bedtime for sustained moisture retention 1
  • Eye taping or patching with careful instruction on proper technique to avoid corneal abrasion 1
  • Moisture chambers (polyethylene covers) for severe cases 1

Urgent Ophthalmology Referral Indications

  • Complete inability to close the eye 1
  • Eye pain, vision changes, redness, or discharge 1
  • Signs of corneal exposure or damage 1

Diagnostic Testing Approach

Do NOT order routine laboratory tests or imaging for typical Bell's palsy presentations—this only delays treatment without improving outcomes. 1

When to Order Tests

Electrodiagnostic testing (ENoG/EMG): Offer only to patients with complete facial paralysis, performed 3-14 days post-onset. 1 Testing before 7 days or after 14-21 days is unreliable. 1

MRI with and without contrast: Order only for atypical features: 1

  • Recurrent paralysis on same side
  • Isolated branch paralysis (not affecting forehead)
  • Other cranial nerve involvement
  • Progressive weakness beyond 3 weeks
  • No recovery after 3 months
  • Bilateral facial weakness

Follow-Up Schedule

Early Follow-Up (1-2 Weeks)

  • Assess recovery trajectory 2
  • Reinforce eye protection compliance 2
  • Monitor for complications 2

Mandatory 3-Month Reassessment

Refer to facial nerve specialist if facial recovery is incomplete at 3 months. 1 Approximately 30% of patients may experience permanent facial weakness requiring reconstructive options. 1

Urgent Reassessment Triggers (Any Time)

  • New or worsening neurologic findings 1
  • Development of ocular symptoms 1
  • Progressive weakness beyond expected timeline 1

Special Populations

Diabetes

Diabetes is NOT a contraindication to corticosteroids—the therapeutic benefit outweighs temporary hyperglycemia risk. 1

  • Monitor capillary glucose every 2-4 hours during first few days 1
  • Dose steroids in the morning to align with cortisol rhythm 1
  • Increase basal insulin and add/increase prandial insulin proactively 1
  • Consider adding NPH insulin concurrent with morning steroid dose 1

Pregnancy

Treat pregnant women with oral corticosteroids within 72 hours using individualized risk-benefit assessment. 1 Eye protection measures are essential and safe in pregnancy. 1

Children

Children have better prognosis with higher spontaneous recovery rates than adults. 1, 2 Evidence for corticosteroid benefit in children is less conclusive, so involve caregivers in shared decision-making. 1 Use weight-based dosing: prednisolone 1 mg/kg/day (maximum 50-60 mg) for 5 days, then 5-day taper. 1


Therapies NOT Recommended

Do not use: 1

  • Physical therapy (no proven benefit over spontaneous recovery)
  • Acupuncture (poor-quality trials, indeterminate benefit-harm ratio)
  • Surgical decompression (rarely indicated except in specialized trauma cases)

Expected Recovery Timeline

  • Most patients begin recovery within 2-3 weeks 1, 2
  • Complete recovery typically occurs within 3-4 months 1
  • Incomplete paralysis: up to 94% complete recovery 1, 2
  • Complete paralysis: approximately 70% complete recovery within 6 months 1, 2

Common Pitfalls to Avoid

  • Starting steroids after 72 hours: No proven benefit and exposes patients to medication risks unnecessarily 1, 2
  • Using antivirals alone: Completely ineffective as monotherapy 1, 2
  • Inadequate eye protection: Can lead to permanent corneal damage, especially with severe lagophthalmos 1
  • Failing to refer at 3 months: Delays access to reconstructive options and psychological support 1
  • Ordering unnecessary imaging: Delays treatment in typical presentations 1
  • Using standard methylprednisolone dose packs: These provide only 105 mg prednisone equivalent versus the required 540 mg over 14 days, representing significant underdosing 1

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bell's Palsy at Day 5

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early treatment with prednisolone or acyclovir in Bell's palsy.

The New England journal of medicine, 2007

Research

Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.